Excessive elevation of TGF-β1, a key profibrotic driver, is involved in diverse fibrotic diseases, such as cirrhosis, Crohn’s disease, glomerulosclerosis, cardiac fibrosis, diabetic nephropathy, pulmonary fibrosis, and myocarditis in humans [28,30]. Here, TGFB1 is linked to pulmonary fibrosis.